ESRRA and osteosarcoma: Furthermore, ERRα was found to increase transcription of ABCB1, and XCT-790 decreased mRNA stability of ABCB1, suggesting that targeting ERRα could have potential in restoring chemotherapy resistance in osteosarcoma [405].